Pharmaceutical giants accused of unethical advertising tactics for weight-loss injectable drugs Wegovy and Mounjaro

Novo Nordisk and Eli Lilly, manufacturers of weight-loss injectable drugs Wegovy and Mounjaro, are under fire for their advertising campaigns. The campaigns, which direct viewers to talk to their doctor about their weight, skirt the Therapeutic Goods Administration's strict rules on direct-to-consumer advertising of prescription drugs. Experts argue that the ads push the boundaries of the law to increase company profits. The companies claim their campaigns are aimed at raising awareness of obesity as a chronic disease.